MA26657A1 - Derives de cephalosporine, procede pour les preparer, medicaments les contenant, et leur utilisation dans le traitement de la prophylaxie de maladies infectieuses. - Google Patents

Derives de cephalosporine, procede pour les preparer, medicaments les contenant, et leur utilisation dans le traitement de la prophylaxie de maladies infectieuses.

Info

Publication number
MA26657A1
MA26657A1 MA25640A MA25640A MA26657A1 MA 26657 A1 MA26657 A1 MA 26657A1 MA 25640 A MA25640 A MA 25640A MA 25640 A MA25640 A MA 25640A MA 26657 A1 MA26657 A1 MA 26657A1
Authority
MA
Morocco
Prior art keywords
prophylaxis
preparation
treatment
infectious diseases
medicaments containing
Prior art date
Application number
MA25640A
Other languages
English (en)
Inventor
Angehrn Peter
Goetschi Erwin
G F Richter Hans
Heinze-Krauss Ingrid
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of MA26657A1 publication Critical patent/MA26657A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/38—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof
    • C07D501/40—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof with the 7-amino radical acylated by an aliphatic carboxylic acid, which is substituted by hetero atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
MA25640A 1998-06-22 1999-06-21 Derives de cephalosporine, procede pour les preparer, medicaments les contenant, et leur utilisation dans le traitement de la prophylaxie de maladies infectieuses. MA26657A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP98111415 1998-06-22
EP99108149 1999-04-26

Publications (1)

Publication Number Publication Date
MA26657A1 true MA26657A1 (fr) 2004-12-20

Family

ID=26149364

Family Applications (1)

Application Number Title Priority Date Filing Date
MA25640A MA26657A1 (fr) 1998-06-22 1999-06-21 Derives de cephalosporine, procede pour les preparer, medicaments les contenant, et leur utilisation dans le traitement de la prophylaxie de maladies infectieuses.

Country Status (16)

Country Link
US (1) US6583133B1 (fr)
EP (1) EP1090013A1 (fr)
JP (1) JP4033630B2 (fr)
KR (1) KR100414336B1 (fr)
CN (1) CN1173979C (fr)
AU (1) AU761450B2 (fr)
BR (1) BR9911445A (fr)
CA (1) CA2335288A1 (fr)
HU (1) HUP0102350A2 (fr)
ID (1) ID28433A (fr)
IL (1) IL140010A0 (fr)
MA (1) MA26657A1 (fr)
NO (1) NO20006507D0 (fr)
PL (1) PL345266A1 (fr)
TR (1) TR200003807T2 (fr)
WO (1) WO1999067255A1 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20020085176A (ko) * 2001-05-07 2002-11-16 주식회사 엘지생명과학 신규 세팔로스포린계 항생제 및 이의 제조 방법
KR20020085180A (ko) * 2001-05-07 2002-11-16 주식회사 엘지생명과학 신규 세팔로스포린계 항생제 및 이의 제조 방법
ITRM20020014A1 (it) * 2002-01-15 2003-07-15 Sigma Tau Ind Farmaceuti Derivati di acidi a-feniltiocarbossilici e a-fenilossicarbossilici utili per il trattamento di patologie che rispondono all'attivazione del
KR100693298B1 (ko) * 2003-06-27 2007-03-13 영진약품공업주식회사 신규한 세팔로스포린계 화합물 및 약제학적으로 허용되는염과 그의 제조 방법
JP3928086B2 (ja) * 2005-03-29 2007-06-13 塩野義製薬株式会社 ３−プロペニルセフェム誘導体
UA121298C2 (uk) 2013-03-15 2020-05-12 Мерк Шарп І Доум Корп. Антибіотична композиція на основі цефтолозану і тазобактаму

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3983113A (en) * 1975-08-15 1976-09-28 Syntex (U.S.A.) Inc. Cephalosporin type antibacterials
US4486586A (en) 1983-02-10 1984-12-04 Bristol-Myers Company Cephalosporin derivatives
US4751295A (en) 1984-04-09 1988-06-14 Bristol-Myers Company Cephalosporin derivatives
CA1276929C (fr) 1984-04-09 1990-11-27 Masahisa Oka Agents antibacteriens de cephalosporine
FR2622585B1 (fr) 1987-11-03 1991-04-19 Roussel Uclaf Nouvelles cephalosporines comportant en position 3 un radical vinyle substitue, leur procede de preparation, leur application comme medicaments, les compositions les renfermant et les nouveaux intermediaires obtenus
DE68928174T2 (de) * 1988-03-16 1997-12-18 Eisai Co., Ltd., Tokio/Tokyo Verfahren zur Herstellung von Cephemderivaten
EP0503453B1 (fr) 1991-03-08 2001-05-09 Biochemie Gesellschaft M.B.H. Procédé pour la préparation de céphalosporines, ainsi qu'intermédiaires dans ce procédé
AT396108B (de) * 1991-08-21 1993-06-25 Biochemie Gmbh Neues verfahren und neue zwischenprodukte zur herstellung von 7-aminocephalosporansaeurederivaten
US5523400A (en) * 1993-04-16 1996-06-04 Hoffmann-La Roche Inc. Cephalosporin antibiotics
CA2143519A1 (fr) * 1994-03-11 1995-09-12 F. Hoffmann-La Roche Ag Beta-lactames
US5804577A (en) * 1995-09-12 1998-09-08 Hoffmann-La Roche Inc. Cephalosporin derivatives
DE69737382T2 (de) 1996-11-06 2007-10-31 Basilea Pharmaceutica Ag Vinylpyrrolidinon-Cephalosporin-Derivate
US6150350A (en) * 1997-09-15 2000-11-21 Hoffman-La Roche Inc. Antimicrobial compositions

Also Published As

Publication number Publication date
US6583133B1 (en) 2003-06-24
CN1173979C (zh) 2004-11-03
WO1999067255A1 (fr) 1999-12-29
TR200003807T2 (tr) 2001-06-21
ID28433A (id) 2001-05-24
AU761450B2 (en) 2003-06-05
NO20006507L (no) 2000-12-20
CN1306536A (zh) 2001-08-01
IL140010A0 (en) 2002-02-10
JP4033630B2 (ja) 2008-01-16
BR9911445A (pt) 2001-03-20
NO20006507D0 (no) 2000-12-20
AU4608199A (en) 2000-01-10
JP2002518505A (ja) 2002-06-25
PL345266A1 (en) 2001-12-03
CA2335288A1 (fr) 1999-12-29
KR20010053092A (ko) 2001-06-25
KR100414336B1 (ko) 2004-01-07
HUP0102350A2 (hu) 2001-11-28
EP1090013A1 (fr) 2001-04-11

Similar Documents

Publication Publication Date Title
MA26653A1 (fr) Pyrrolo [2,3- d] pyrimidines nouvelles, procede pour leur preparation et compositions pharmaceutiques les contenant
MA26559A1 (fr) Derives de d-proline, procede pour leur preparation, compositions pharmaceutiques les contenant et leur utilisation
MA26654A1 (fr) Pyrrolopyrimidines nouvelles procede pour leur preparation et compositions pharmaceutiques les contenant
FR2780057B1 (fr) Phenoxypropanolamines, procede pour leur preparation et compositions pharmaceutiques les contenant
MA26424A1 (fr) Derives de 6-phenylpyridyl-2-amine, procede pour leur preparation et compositions pharmaceutiques les contenant.
FR2665453B1 (fr) Polylactides purifies, procede pour leur preparation et compositions pharmaceutiques les contenant.
MA26432A1 (fr) Derives de 2-(2-oxo-ethylidene)-imidazolidine-4-one, procede pour leur preparation et compositions pharmaceutiques les contenant.
MA26622A1 (fr) Pyrazolopyrimidinones nouvelles, procede pour leur preparation et compositions pharmaceutiques les contenant
MA26687A1 (fr) 4-carboxyamino-2-methyl-1,2,3,4-tetrahydroquinoleines, procede pour leur preparation et compositions pharmaceutiques les contenant
MA26630A1 (fr) 4-phenylpyperidines nouvelles, procede pour leur preparation et compositions pharmaceutiques les contenant
MA26415A1 (fr) Composes heterocycliques, procede pour la preparation et compositions pharmaceutiques les contenant
MA25493A1 (fr) Derives de 3(5)-amino-pyrazole, procede pour leur preparation et leur utilisation en tant qu'agents antitumoraux.
MA24529A1 (fr) Pyrazolopyrimidinones nouvelles, procede pour leur preparation et compositions les contenant .
MA26499A1 (fr) Derives de tetrazole, procede pour leur preparation et compositions pharmaceutiques les contenant .
FR2612187B1 (fr) Derives du thiazole actifs sur le systeme cholinergique, leur procede de preparation et compositions pharmaceutiques en contenant
FR2663564B1 (fr) Procede pour l'obtention d'agents filtrants diatomiques calcines tres permeables exempts de cristobalite, et agents filtrants diatomitiques calcines tres permeables exempts de cristobalite.
FR2542740B1 (fr) Derives de thiazolidine, procede pour leur preparation et compositions pharmaceutiques les contenant
FI972308A0 (fi) 2-substituoituja 1,2,5-tiadiatsolidin-3-oni-1,1-dioksideja ja niitä sisältäviä koostumuksia ja menetelmiä niiden käyttämiseksi
MA26658A1 (fr) Derivés de valérohydrazine, procédé pour les préparer, médicament pour le traitement des maladies inflammatoires et auto-immunes les contenant, et leur utilisation pour préparer un tel médicament
FR2728901B1 (fr) Derives de phenyl-4-thiazoles substitues, procede pour leur preparation et compositions pharmaceutiques les contenant
MA26582A1 (fr) Derives de thiazolidinedione nouveau, procede pour sa preparation et composition pharmaceutique le contenant
MA26657A1 (fr) Derives de cephalosporine, procede pour les preparer, medicaments les contenant, et leur utilisation dans le traitement de la prophylaxie de maladies infectieuses.
MA26683A1 (fr) Derives de piperidine, procede pour leur preparation, medicaments les contenant et leur utilisation dans le traitement de troubles neurologiques et physiologiques
MA26650A1 (fr) Oxo-thia -azabicyclooctenes, preparations pharmaceutiques les contenant, et leur utilisation pour le traitement et la prophylaxie de maladies infectieuses.
MA26607A1 (fr) Utilisation de derives de piperidine et de pyrrolidine pour le traitement de maladies comprenant des formes de degenerescence neuronale et medicaments les contenant